Key metrics and charts across all fundamental categories.
Stock price and market valuation
CRWD trades at $673.02, a 56.2% increase year-over-year. Market capitalization stands at $170.77B, up 59.5% from the prior year. Track CRWD price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$5.09B in TTM revenue grew 5.7% YoY, reaching $1.39B last quarter. TTM EBITDA of $-199.24M on operating income of $-30.60M shows growth is flowing through. However, net income is negative at $24.52M — growth is not yet reaching the bottom line. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
With $11.27B in assets and $745.84M in long-term debt, the D/E of 0.2 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
P/S of 33.5x and P/B of 36.9x. A high P/S suggests growth expectations are priced in.
Operating efficiency and return metrics
Op. margin of -2.2% is up 9.1% YoY — cost efficiency is improving. Net margin at 2.0% and gross margin of 75.3%. Negative ROE of -0.5% indicates shareholder value is being eroded.
Free cash flow, earnings quality, and capital allocation
FCF of $493.31M on $590.94M in operating cash flow. The FCF / Net Income ratio of -20.1x shows cash consumption — the business is not yet self-funding. Cash reserves of $4.55B provide financial flexibility. Shares outstanding rose 2.1% YoY — shareholder dilution is eroding per-share value.